Prospective Evaluation of Ultrasound-guided Percutaneous Cholecystostomy

Status Recruiting

Clinical Trial Summary

The purpose of this study is to further evaluate and investigate the safety and efficacy of ultrasound (US)-guided percutaneous cholecystostomy (PC) with the trocar technique by the patient's bedside.

Clinical Trial Description

This clinical study will include patients who will undergo US-guided PC with the trocar technique. The study will include all cases requiring PC regardless of the underlying cause, while those requiring computed tomography (CT) guidance and those with uncontrolled coagulation disorders will be excluded. Patient demographics, height, weight, and body mass index (BMI), comorbidities, ASA score, presence or absence of stones, presence or absence of gallbladder perforation at diagnosis, presence or absence of concomitant ascitic effusion, days of preoperative antibiotic treatment, imaging modality used to establish the diagnosis, technical details of the procedure, laboratory values (before and after surgery), and contact information for patient monitoring will be recorded. The technical success of the method as well as its complications during hospitalization and during a 3-month follow-up period will be calculated. In addition, the anatomical access route during the PC (transhepatic/transperitoneal and intercostal/subcostal), the duration of the operation, the intraoperative and postoperative pain, and the clinical success of the method will be recorded. After the operation, the patients will be monitored clinically and with laboratory test and, if deemed necessary, US, CT or both imaging will be performed. Before discharge, written instructions will be given regarding the management and care of the catheter. This study will not burden the hospital financially, as the clinical, laboratory, and imaging tests required for the diagnosis of the underlying etiology that leads to the need to perform the procedure, the technique used to perform the procedure, as well as the monitoring of the patients and the possible complications of the procedure, are part of the hospital's routine. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06330688
Study type	Observational [Patient Registry]
Source	Attikon Hospital
Contact	Stavros Spiliopoulos, MD, PhD, Associate Professor
Phone	+302105831812
Email	stavspiliop@gmail.com
Status	Recruiting
Phase
Start date	March 2024
Completion date	June 2026

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03636841` - Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis	N/A
Completed	`NCT02379780` - Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy	N/A
Completed	`NCT02461147` - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Completed	`NCT02264444` - Establishing Visualization Grading Scale on LESS Cholecystectomy	N/A
Completed	`NCT01937104` - ONSD According to the Position During Laparoscopy	N/A
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT00940264` - Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection.	N/A
Completed	`NCT00746850` - Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis	N/A
Completed	`NCT00370344` - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease	Phase 2/Phase 3
Completed	`NCT00195351` - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection	Phase 4
Completed	`NCT02858986` - 3D Versus 4K Laparoscopic Cholecystectomy	N/A
Completed	`NCT04602156` - US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy	N/A
Completed	`NCT04942665` - Low Dose ICG for Biliary Tract and Tumor Imaging	Phase 2
Completed	`NCT02547064` - Effect of Modified Stylet Angulation on the Intubation With GlideScope®	N/A
Completed	`NCT00230971` - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)	Phase 4
Completed	`NCT04122261` - A Clinical Study of Chinese Domestic Surgical Robot	N/A
Completed	`NCT04716166` - Incentive Spirometry and Upper Abdominal Laparoscopic Surgery	N/A
Completed	`NCT01476319` - Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department	N/A
Withdrawn	`NCT02225418` - Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy	N/A
Suspended	`NCT04306939` - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prospective Evaluation of Ultrasound-guided Percutaneous Cholecystostomy With the Trocar Technique

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms